Table 1.

Norcantharidin (NCTD) arrests cell cycle progression in human umbilical vein endothelial cells (HUVECs)

Population (%)	Norcantharidin (μmol/L)
	0	5	10	20	40
G0/G1 phase	51.39 ± 1.99	60.39 ± 3.95	65.44 ± 2.71	70.39 ± 2.38	76.06 ± 2.55
G2/M phase	33.95 ± 3.07	25.17 ± 1.49	20.61 ± 2.03	14.78 ± 1.56	12.57 ± 1.21